SFU
AGIO icon

Stonehage Fleming (UK)’s Agios Pharmaceuticals AGIO Stock Holding History

Stonehage Fleming (UK)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-450
Closed -$28K – 294
2014
Q3 		$28K Sell
450
-452
-50% -$19.5K 0.01% 220
2014
Q2 		$41K Sell
902
-681
-43% -$27.8K 0.02% 174
2014
Q1 		$62K Sell
1,583
-593
-27% -$19.8K 0.03% 225
2013
Q4 		$52K Buy
+2,176
New +$49.6K 0.02% 220

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

Stonehage Fleming (UK)'s AGIO Position: Q4 2014 in Review

Stonehage Fleming (UK) sold out of Agios Pharmaceuticals (AGIO) in Q4 2014, closing a stake of 450 shares — an estimated $28K sold.

Stonehage Fleming (UK) first reported a position in AGIO in Q4 2013 and held it in 4 quarters. The position peaked at $62K in Q1 2014. 142 funds tracked by Wall St. Rank hold AGIO as of Q4 2014.

  • Stonehage Fleming (UK) reported no remaining Agios Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 450 Agios Pharmaceuticals shares in Q4 2014, an estimated $28K.
  • Stonehage Fleming (UK) first reported a position in Agios Pharmaceuticals in Q4 2013 and held it in 4 quarters.
  • Stonehage Fleming (UK)'s Agios Pharmaceuticals position peaked at $62K in Q1 2014.
  • 142 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2014.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2014, filed 11 Oct 2019.